Of note, the tumor of patient RNA-1 had only 20% of ER-positive cells, as well as a low abundance of ESR1 and PGR transcripts, which could explain its poor response to endocrine treatment (SI Appendix, List S1). The gene discussed is ESR1; the disease is neoplasm.